Reported impact
Business outcome
NovoScribe reduced CSR creation from 12 weeks to 10 minutes, improved output quality, reduced staffing requirements, and accelerated time-to-market for new treatments.
- Productivity Improvement
- Revenue Growth
- Speed to Market
Solution
Novo Nordisk created the NovoScribe platform to automate Clinical Study Report production with a retrieval-augmented generation architecture built on MongoDB Atlas Vector Search, Amazon Bedrock, and LangChain. Statistical outputs from clinical trials, report templates, and supporting documentation are prepared as structured tables, figures, and vectorized content inside MongoDB Atlas. LangChain orchestrates multiple Bedrock-hosted foundation models, including Claude 3 and Titan, as well as the company's private ChatGPT instance, so teams can switch models without rewriting application code. Atlas Vector Search supplies the relevant template sections and report evidence back into the prompting flow, grounding generation in the right trial context. The system therefore replaces slow manual compilation, merging, and QA-heavy handoffs with a governed AI pipeline that drafts complete CSRs in minutes, while still allowing Novo Nordisk to compare model behavior and iterate quickly as requirements evolve.
Data flow
Clinical trial data is analyzed into tables and figures, templates and evidence are embedded in MongoDB Atlas, LangChain orchestrates Bedrock-hosted models such as Claude 3 and Titan, and MongoDB Atlas Vector Search feeds the right context back into the prompts so NovoScribe can assemble full clinical study reports in minutes.